US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 11.070
  • -0.290-2.55%
Trading Apr 25 15:32 ET
549.42MMarket Cap-6332P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
168.93%84.66M
176.89%27.71M
253.94%26.27M
142.86%15.74M
97.36%14.94M
68.11%31.48M
41.30%10.01M
7.42M
6.48M
7.57M
Selling and administrative expenses
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
116.34%5.23M
368.95%2.19M
--1.36M
--884K
--791K
-General and administrative expense
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
116.34%5.23M
368.95%2.19M
--1.36M
--884K
--791K
Research and development costs
168.04%70.36M
202.95%23.69M
271.33%22.5M
112.40%11.88M
81.37%12.29M
60.96%26.25M
18.17%7.82M
--6.06M
--5.6M
--6.78M
Operating profit
-168.93%-84.66M
-176.89%-27.71M
-253.94%-26.27M
-142.86%-15.74M
-97.36%-14.94M
-68.11%-31.48M
-41.30%-10.01M
-7.42M
-6.48M
-7.57M
Net non-operating interest income expense
661.10%12.76M
255.19%3.32M
374.09%3.51M
3.59M
2.33M
6,307.41%1.68M
935K
741K
0
0
Non-operating interest income
661.10%12.76M
255.19%3.32M
374.09%3.51M
--3.59M
--2.33M
--1.68M
--935K
--741K
--0
--0
Other net income (expense)
-25.00%3K
1K
1K
1K
100.61%4K
0
4K
Other non- operating income (expenses)
-25.00%3K
--1K
----
--1K
--1K
300.00%4K
--0
--4K
----
----
Income before tax
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
-7.57M
Income tax
Net income
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
-7.57M
Net income continuous Operations
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
---6.68M
---6.48M
---7.57M
Minority interest income
Net income attributable to the parent company
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
-7.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
-7.57M
Basic earnings per share
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
79.74%-0.763
83.01%-0.2323
-1.29
-1.2504
-1.4608
Diluted earnings per share
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
79.74%-0.763
83.01%-0.2323
-1.29
-1.2504
-1.4608
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 168.93%84.66M176.89%27.71M253.94%26.27M142.86%15.74M97.36%14.94M68.11%31.48M41.30%10.01M7.42M6.48M7.57M
Selling and administrative expenses 173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M116.34%5.23M368.95%2.19M--1.36M--884K--791K
-General and administrative expense 173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M116.34%5.23M368.95%2.19M--1.36M--884K--791K
Research and development costs 168.04%70.36M202.95%23.69M271.33%22.5M112.40%11.88M81.37%12.29M60.96%26.25M18.17%7.82M--6.06M--5.6M--6.78M
Operating profit -168.93%-84.66M-176.89%-27.71M-253.94%-26.27M-142.86%-15.74M-97.36%-14.94M-68.11%-31.48M-41.30%-10.01M-7.42M-6.48M-7.57M
Net non-operating interest income expense 661.10%12.76M255.19%3.32M374.09%3.51M3.59M2.33M6,307.41%1.68M935K741K00
Non-operating interest income 661.10%12.76M255.19%3.32M374.09%3.51M--3.59M--2.33M--1.68M--935K--741K--0--0
Other net income (expense) -25.00%3K1K1K1K100.61%4K04K
Other non- operating income (expenses) -25.00%3K--1K------1K--1K300.00%4K--0--4K--------
Income before tax -141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M-7.57M
Income tax
Net income -141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M-7.57M
Net income continuous Operations -141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M---6.68M---6.48M---7.57M
Minority interest income
Net income attributable to the parent company -141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M-7.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M-7.57M
Basic earnings per share -160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.5179.74%-0.76383.01%-0.2323-1.29-1.2504-1.4608
Diluted earnings per share -160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.5179.74%-0.76383.01%-0.2323-1.29-1.2504-1.4608
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg